AmCad BioMed

AmCad BioMed EBIT per Share

The EBIT per Share of AmCad BioMed (4188.TWO) as of Nov 1, 2026 is -1.60 TWD. In the previous year, EBIT per Share was -1.17 TWD — a change of 36.02% (lower).

EBIT per Share

-1.60TWD

YoY

36.02%

Last updated:

EBIT per Share of AmCad BioMed is 2025 -1.60 TWD. EBIT per Share of AmCad BioMed was 2024 -1.17 TWD. It decreases by 36.02% lower compared to the previous year.

The AmCad BioMed EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-1.52 TWD
Jan 1, 2019
-1.06 TWD
Jan 1, 2020
-0.78 TWD
Jan 1, 2021
-0.49 TWD
Jan 1, 2022
-0.99 TWD
Jan 1, 2023
-0.80 TWD
Jan 1, 2024
-1.17 TWD
Jan 1, 2025
-1.60 TWD
The AmCad BioMed EBIT per Share history
YEAREBIT per ShareYoY
-1.60TWD+36.02%
-1.17TWD+46.35%
-0.80TWD-18.59%
-0.99TWD+102.18%
-0.49TWD-37.33%
-0.78TWD-26.82%
-1.06TWD-30.10%
-1.52TWD+25.11%
-1.21TWD-4.22%
-1.27TWD-18.44%
-1.56TWD+28.23%
-1.21TWD+2.81%
-1.18TWD-24.87%
-1.57TWD-36.38%
-2.47TWD+55.88%
-1.58TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

AmCad BioMed Stock analysis

What does AmCad BioMed do? AmCad BioMed Corp, headquartered in Taipei City, Taiwan, specializes in manufacturing and selling medical diagnostic software devices. The company offers products like AmCAT-UT Detection, a computer-aided detection system for thyroid ultrasound, and AmCAD-UT Diagnosis, a computer-aided diagnosis system for the same purpose. Listed on 26 December 2013, AmCad BioMed operates in Taiwan, China, and Hong Kong markets. AmCad BioMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AmCad BioMed stock

EBIT per Share of AmCad BioMed is -1.60 TWD in 2025.

EBIT per Share of AmCad BioMed changed from -1.17 TWD to -1.60 TWD, representing a 36.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share AmCad BioMed since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — AmCad BioMed

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — AmCad BioMed